DBTX - Decibel Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

DBTX is currently covered by 3 analysts with an average price target of $11.83. This is a potential upside of $6.92 (140.94%) from yesterday's end of day stock price of $4.91.

Decibel Therapeutics's activity chart (see below) currently has 9 price targets and 12 ratings on display. The stock rating distribution of DBTX is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Highest price target for DBTX is $5.25, Lowest price target is $5.25, average price target is $11.83.

Most recent stock forecast was given by JACK ALLEN from BAIRD on 10-Aug-2023. First documented stock forecast 09-Mar-2021.

Best performing analysts who are covering DBTX - Decibel Therapeutics:

Mani Foroohar Joseph Pantginis Jack Allen Matthew Luchini Gena Wang

Currently out of the existing stock ratings of DBTX, 2 are a BUY (50%), 2 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

5.25

$0.34 (6.92%)

21

8 months 9 days ago

0/2 (0%)

$0.09 (1.74%)

Hold

23

8 months 10 days ago

0/1 (0%)

$15.49 (206.26%)

Buy

2

$-2.91 (-59.27%)

7

1 years 1 months 4 days ago

0/5 (0%)

$-1.51 (-43.02%)

Buy

7

$2.09 (42.57%)

30

2 years 29 days ago

0/2 (0%)

$3.97 (131.02%)

Buy

24

$19.09 (388.80%)

2 years 8 months 8 days ago

0/1 (0%)

$16.54 (221.72%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DBTX (Decibel Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on DBTX (Decibel Therapeutics) with a proven track record?

MANI FOROOHAR

Which analyst has the current lower performing score on DBTX (Decibel Therapeutics) with a proven track record?

GENA WANG

Which analyst has the most public recommendations on DBTX (Decibel Therapeutics)?

Mani Foroohar has 9 price targets and 7 ratings on DBTX

Which analyst is the currently most bullish on DBTX (Decibel Therapeutics)?

Matthew Luchini with highest potential upside - $19.09

Which analyst is the currently most reserved on DBTX (Decibel Therapeutics)?

Mani Foroohar with lowest potential downside - -$2.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?